サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786929

胃がん診断薬市場、規模、シェア、動向、産業分析レポート：製品タイプ別、疾患タイプ別、最終用途別、地域別 - 市場予測、2025～2034年

Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
胃がん診断薬市場、規模、シェア、動向、産業分析レポート：製品タイプ別、疾患タイプ別、最終用途別、地域別 - 市場予測、2025～2034年
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の胃がん診断市場規模は2034年までに27億8,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

胃がん診断市場は、胃がんの検出と確認に使用される様々な方法と技術に焦点を当てています。これには、ヘルスケアの専門家が病気の早期発見、広がり判定、適切な治療計画の立案に使用するさまざまな医学的検査、処置、評価が含まれます。これらの診断アプローチには、画像検査、内視鏡検査、組織生検、血液検査、高度な分子解析などが含まれ、これらはすべて正確でタイムリーな診断を提供することを目的としています。

胃がん診断薬市場の成長は、世界中で胃がん症例数が増加していることに起因しており、当然ながら診断サービスに対する需要も高まっています。さらに、がんを早期に発見することで治療が成功することが多いため、検診プログラムによる早期発見が重視されるようになっています。この業界はまた、現在進行中の技術的進歩からも恩恵を受けており、より新しく、より正確で、より侵襲性の低い診断ツールが利用できるようになり、より効果的に病気を特定し、個々の患者に合わせた治療を行うのに役立っています。

胃がん診断市場レポートハイライト

製品別では、ルーチンの血液検査から高度な分子分析まで、ほとんどすべての診断検査に試薬と消耗品が不可欠であるため、試薬・消耗品セグメントが2024年に最大のシェアを占めました。

疾患タイプ別では、胃がんの最も一般的な形態として圧倒的な普及率を誇る腺がんが2024年に最大シェアを占めました。診断の努力と資源配分の大部分は、当然ながらこの広範な病型の同定と特徴づけに向けられています。

エンドユース別では、病院セグメントが2024年に最大のシェアを占めました。病院は、患者が一般的に初期診断を受け、内視鏡処置を受け、包括的な診断インフラを利用する主要ヘルスケア施設であるためです。

北米の胃がん診断市場が2024年に最大のシェアを占めたのは、高度なヘルスケアインフラ、早期診断に関する高い意識、精密医療への強い関心のためです。アジア太平洋市場は、特に東アジア諸国における世界の胃がん罹患率の高さに牽引され、急速に拡大しています。

同市場の主要企業には、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、QIAGEN、Bio-Rad Laboratories, Inc.、Agilent Technologies, Inc.、Illumina, Inc.、Myriad Genetics, Inc.、Mirxes Pte.Ltd.、Vela Diagnostics、BIOMERIEUX、AI Medical Service Inc. などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の胃がん診断市場の洞察

  • 市場スナップショット
  • 胃がん診断市場力学
    • 促進要因と機会
      • 胃がんの世界的発生率の上昇
      • 診断技術の進歩
    • 抑制要因と課題
      • 限られた早期発見方法
  • PESTEL分析
  • 胃がん診断市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の胃がん診断市場：製品別

  • 主な調査結果
  • イントロダクション
  • 試薬と消耗品
  • 機器

第6章 世界の胃がん診断市場：疾患タイプ別

  • 主な調査結果
  • イントロダクション
  • 腺がん
  • 胃リンパ腫
  • その他

第7章 世界の胃がん診断市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 診断検査室
  • 診断画像

第8章 世界の胃がん診断市場：地域

  • 主な調査結果
  • イントロダクション
    • 胃がん診断市場分析：地域、2020年～2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：疾患別、2020～2034年
    • 北米：最終用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：疾患別、2020～2034年
    • 欧州：最終用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：疾病タイプ別、2020～2034年
    • アジア太平洋地域：最終用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：疾病タイプ別、2020～2034年
    • 中東・アフリカ：最終用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：疾病タイプ別、2020-2034年
    • ラテンアメリカ：最終用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AI Medical Service Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Mirxes Pte. Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN
  • Vela Diagnostics
図表

List of Tables:

  • Table 1 Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 3 Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 6 North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 9 U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 12 Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 15 Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 18 UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 21 France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 24 Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 27 Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 36 Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 45 China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 48 India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 54 Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 60 South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 63 Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 75 UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 78 Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 81 South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 87 Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 90 Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 93 Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 96 Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Gastric Cancer Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Gastric Cancer Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Gastric Cancer Diagnostics Market, by Disease Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Gastric Cancer Diagnostics Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM5915

The global gastric cancer diagnostics market size is expected to reach USD 2.78 billion by 2034, according to a new study by Polaris Market Research. The report "Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gastric cancer diagnostics market focuses on the various methods and technologies used to detect and confirm stomach cancer. This involves a range of medical tests, procedures, and evaluations that healthcare professionals use to identify the disease in its early stages, determine its spread, and guide appropriate treatment plans. These diagnostic approaches include imaging studies, endoscopic examinations, tissue biopsies, blood tests, and advanced molecular analyses, all aimed at providing an accurate and timely diagnosis.

The gastric cancer diagnostics market growth is attributed to the increasing number of gastric cancer cases around the world, which naturally leads to a higher demand for diagnostic services. Additionally, there is a growing emphasis on early detection through screening programs, as finding the cancer early often improves treatment success. The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available, which helps identify the disease more effectively and tailoring treatments to individual patients.

Gastric Cancer Diagnostics Market Report Highlights

By product, the reagents & consumables segment held the largest share in 2024 as reagents and consumables are essential for almost every diagnostic test, from routine blood work to advanced molecular analyses.

By disease type, the adenocarcinoma segment held the largest share in 2024, due to its overwhelming prevalence as the most common form of gastric cancer. The majority of diagnostic efforts and resource allocation are naturally directed toward identifying and characterizing this widespread disease type.

By end use, the hospitals segment held the largest share in 2024 as they are the primary healthcare facilities where patients typically receive initial diagnoses, undergo endoscopic procedures, and access comprehensive diagnostic infrastructure.

The North America gastric cancer diagnostics market accounted for the largest share in 2024, due to advanced healthcare infrastructure, high awareness regarding early diagnosis, and a strong focus on precision medicine. The market in Asia Pacific is expanding rapidly, driven by the highest global incidence of gastric cancer, particularly in East Asian countries.

A few key players in the market include F. Hoffmann-La Roche Ltd.; Abbott Laboratories; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Mirxes Pte. Ltd.; Vela Diagnostics; BIOMERIEUX; and AI Medical Service Inc.

Polaris Market Research has segmented the gastric cancer diagnostics market report on the basis of product, disease type, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Reagents & Consumables

Instruments

By Disease Type Outlook (Revenue - USD Billion, 2020-2034)

Adenocarcinoma

Gastric lymphoma

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Diagnostic Imaging

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Gastric Cancer Diagnostics Market Insights

  • 4.1. Gastric Cancer Diagnostics Market - Market Snapshot
  • 4.2. Gastric Cancer Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Incidence of Gastric Cancer
      • 4.2.1.2. Advancements in Diagnostic Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited early detection methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gastric Cancer Diagnostics Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gastric Cancer Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Reagents & Consumables
    • 5.3.1. Global Gastric Cancer Diagnostics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Gastric Cancer Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)

6. Global Gastric Cancer Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • 6.3. Adenocarcinoma
    • 6.3.1. Global Gastric Cancer Diagnostics Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
  • 6.4. Gastric lymphoma
    • 6.4.1. Global Gastric Cancer Diagnostics Market, by Gastric lymphoma, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gastric Cancer Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.5. Diagnostic Imaging
    • 7.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Gastric Cancer Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gastric Cancer Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Gastric Cancer Diagnostics Market - North America
    • 8.3.1. North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Gastric Cancer Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Gastric Cancer Diagnostics Market - Canada
      • 8.3.5.1. Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Gastric Cancer Diagnostics Market - Europe
    • 8.4.1. Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Gastric Cancer Diagnostics Market - UK
      • 8.4.4.1. UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Gastric Cancer Diagnostics Market - France
      • 8.4.5.1. France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Gastric Cancer Diagnostics Market - Germany
      • 8.4.6.1. Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Gastric Cancer Diagnostics Market - Italy
      • 8.4.7.1. Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Gastric Cancer Diagnostics Market - Spain
      • 8.4.8.1. Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Gastric Cancer Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Gastric Cancer Diagnostics Market - Russia
      • 8.4.10.1. Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Gastric Cancer Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Gastric Cancer Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Gastric Cancer Diagnostics Market - China
      • 8.5.4.1. China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Gastric Cancer Diagnostics Market - India
      • 8.5.5.1. India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Gastric Cancer Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Gastric Cancer Diagnostics Market - Japan
      • 8.5.7.1. Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Gastric Cancer Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Gastric Cancer Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Gastric Cancer Diagnostics Market - Australia
      • 8.5.10.1. Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Gastric Cancer Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Gastric Cancer Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Gastric Cancer Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Gastric Cancer Diagnostics Market - UAE
      • 8.6.5.1. UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Gastric Cancer Diagnostics Market - Israel
      • 8.6.6.1. Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Gastric Cancer Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Gastric Cancer Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Gastric Cancer Diagnostics Market - Latin America
    • 8.7.1. Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Gastric Cancer Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Gastric Cancer Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Gastric Cancer Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Gastric Cancer Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AI Medical Service Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BIOMERIEUX
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bio-Rad Laboratories, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mirxes Pte. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. QIAGEN
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Vela Diagnostics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development